StreetInsider.com News Articles

Form 4 Alignment Healthcare, For: Mar 04 Filed by: Wagner Andreas P.

Wed, 04 Mar 2026 17:24:00 -0500

si-local-file:///var/storage/secattach/20260304/26112792.html

Form 4 Alignment Healthcare, For: Mar 04 Filed by: Wagner Andreas P.

Wed, 04 Mar 2026 17:24:00 -0500

si-local-file:///var/storage/secattach/20260304/26112792.html

Form 144 Alignment Healthcare, Filed by: Wagner Andreas P.

Wed, 04 Mar 2026 16:41:00 -0500

si-local-file:///var/storage/secattach/20260304/26112084.html

Form 144 Alignment Healthcare, Filed by: Wagner Andreas P.

Wed, 04 Mar 2026 16:41:00 -0500

si-local-file:///var/storage/secattach/20260304/26112084.html

Form 8-K Alignment Healthcare, For: Mar 02

Wed, 04 Mar 2026 16:09:00 -0500

si-local-file:///var/storage/secattach/20260304/26111098.html

Form 8-K Alignment Healthcare, For: Mar 02

Wed, 04 Mar 2026 16:09:00 -0500

si-local-file:///var/storage/secattach/20260304/26111098.html

Form 424B7 Alignment Healthcare,

Tue, 03 Mar 2026 15:14:00 -0500

si-local-file:///var/storage/secattach/20260303/26100629.html

Form 424B7 Alignment Healthcare,

Tue, 03 Mar 2026 15:14:00 -0500

si-local-file:///var/storage/secattach/20260303/26100629.html

Alignment Healthcare prices secondary offering at $19.46 per share

Mon, 02 Mar 2026 21:05:12 -0500

Alignment Healthcare Inc. (NASDAQ: ALHC) announced the pricing of a secondary offering of 13,167,733 shares of common stock at $19.46 per share. The shares are being sold by an affiliate of General Atlantic L.P., with the company receiving no proceeds from the sale.

J.P. Morgan Securities LLC is serving as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions.

The offering is being conducted under a shelf registration statement on Form S-3 that became effective upon filing with the Securities and Exchange Commission on March 2, 2026. The total value of the

Alignment Healthcare prices secondary offering at $19.46 per share

Mon, 02 Mar 2026 21:05:12 -0500

J.P. Morgan Securities LLC is serving as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions.

The offering is being conducted under a shelf registration statement on Form S-3 that became effective upon filing with the Securities and Exchange Commission on March 2, 2026. The total value of the

Alignment Healthcare prices secondary offering at $19.46 per share

Mon, 02 Mar 2026 21:05:12 -0500

J.P. Morgan Securities LLC is serving as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions.

The offering is being conducted under a shelf registration statement on Form S-3 that became effective upon filing with the Securities and Exchange Commission on March 2, 2026. The total value of the

Alignment Healthcare prices secondary offering at $19.46 per share

Mon, 02 Mar 2026 21:05:12 -0500

J.P. Morgan Securities LLC is serving as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions.

The offering is being conducted under a shelf registration statement on Form S-3 that became effective upon filing with the Securities and Exchange Commission on March 2, 2026. The total value of the

Alignment Healthcare prices secondary offering at $19.46 per share

Mon, 02 Mar 2026 21:05:12 -0500

J.P. Morgan Securities LLC is serving as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions.

The offering is being conducted under a shelf registration statement on Form S-3 that became effective upon filing with the Securities and Exchange Commission on March 2, 2026. The total value of the

Alignment Healthcare prices secondary offering at $19.46 per share

Mon, 02 Mar 2026 21:05:12 -0500

J.P. Morgan Securities LLC is serving as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions.

The offering is being conducted under a shelf registration statement on Form S-3 that became effective upon filing with the Securities and Exchange Commission on March 2, 2026. The total value of the

Alignment Healthcare Announces Pricing of Secondary Offering